Company Profile

Da Yu Enterprises LLC
Profile last edited on: 12/12/13      CAGE: 6R9V5      UEI: Q46MM457BCF6

Business Identifier: Development of a scalable and flexible in vitro protein synthesis system and a rapid macromolecular analytical separation system
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

PO Box 571
Yardley, PA 19067
   (215) 337-9491
Location: Single
Congr. District: 01
County: Bucks

Public Profile

Da Yu Enterprises LLC is a biomedical research and development company pursuing technologies to develop the next generation of therapeutic molecules and providing these services to customers, including non-profit and for-profit biomedical research and development organizations and academic institutions of higher education. In the area of drug discovery and development, the firms’ products used in both the pharmaceutical and biotechnology industries, with product development efforts focused on two enabling technologies critical to biomedical research and development.Da Yu Enterprises offers multiple scientific services that can be either consultative or laboratory-based to biopharmaceutical customers, industrial CMC programs, academic science institutions and engineering firms. Services include CMC Consulting, ranging from pre-IND stage programs to Biologics licensure; Technical Consulting to complement CMC consulting service; Analytical Consulting, supporting product characterization and conducted in a non-GMP environment; and Biophysical Services to support product structural characterization

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 1 NSF $145,036
Project Title: Production of Properly-Folded Recombinant Proteins in Eschericihia coli

Key People / Management

  Donald O'keefe -- Managing Director

Company News

There are no news available.